Evidence of evolution towards left midventricular obstruction in severe Anderson-Fabry cardiomyopathy

Francesca Graziani1, Rosa Lillo2, Elena Panaioli2

  • 1Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

ESC Heart Failure
|November 19, 2020
PubMed

Insights

Fabry cardiomyopathy can progress to a midventricular obstructive form in men with severe left ventricular hypertrophy (LVH). This occurs even with timely enzyme replacement therapy, suggesting a potential adverse disease outcome.

Area of Science:

  • Cardiology
  • Genetics
  • Rare Diseases

Background:

  • Fabry cardiomyopathy is a genetic disorder causing progressive cardiac damage.
  • Left ventricular outflow tract obstruction is a rare complication, often mimicking hypertrophic cardiomyopathy.
  • Severe left ventricular hypertrophy (LVH) is a hallmark of advanced Fabry cardiomyopathy.

Purpose of the Study:

  • To investigate the evolution of cardiac phenotype in Fabry disease patients.
  • To identify specific patterns of LVH leading to left ventricular outflow tract obstruction.
  • To describe a newly observed midventricular obstructive form of Fabry cardiomyopathy.

Main Methods:

  • Case series of three classically affected male patients with Fabry disease.
  • Analysis of cardiac imaging to assess left ventricular hypertrophy (LVH) and obstruction.
  • Evaluation of disease progression despite enzyme replacement therapy.

Main Results:

  • All patients developed a midventricular obstructive phenotype over time.
  • Massive LVH involving papillary muscles was the primary cause of obstruction.
  • This obstruction pattern differed from typical hypertrophic cardiomyopathy.

Conclusions:

  • Fabry cardiomyopathy can evolve into a midventricular obstructive form.
  • This progression is linked to significant diagnostic delay and severe LVH prior to treatment.
  • The midventricular obstructive phenotype may represent an adverse outcome of Fabry disease.
Abstract

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
271
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
198
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
229
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
102
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
185
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
324